Literature DB >> 1463747

Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles.

B Dahlbäck1, T Wiedmer, P J Sims.   

Abstract

Vitamin K-dependent protein S is an anticoagulant plasma protein serving as cofactor to activated protein C in degradation of coagulation factors Va and VIIIa on membrane surfaces. In addition, it forms a noncovalent complex with complement regulatory protein C4b-binding protein (C4BP), a reaction which inhibits its anticoagulant function. Both forms of protein S have affinity for negatively charged phospholipids, and the purpose of the present study was to elucidate whether they bind to the surface of activated platelets or to platelet-derived microparticles. Binding of protein S to human platelets stimulated with various agonists was examined with FITC-labeled monoclonal antibodies and fluorescence-gated flow cytometry. Protein S was found to bind to membrane microparticles which formed during platelet activation but not to the remnant activated platelets. Binding to microparticles was saturable and maximum binding was seen at approximately 0.4 microM protein S. It was calcium-dependent and reversed after the addition of EDTA. Inhibition experiments with monoclonal antibodies suggested the gamma-carboxyglutamic acid containing module of protein S to be involved in the binding reaction. An intact thrombin-sensitive region of protein S was not required for binding. The protein S-C4BP complex did not bind to microparticles or activated platelets even though it bound to negatively charged phospholipid vesicles. Intact protein S supported binding of both protein C and activated protein C to microparticles. Protein S-dependent binding of protein C/activated protein C was blocked by those monoclonal antibodies against protein S that inhibited its cofactor function. In conclusion, we have found that free protein S binds to platelet-derived microparticles and stimulates binding of protein C/activated protein C.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463747     DOI: 10.1021/bi00166a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

2.  Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.

Authors:  D Borgel; P Gaussem; C Garbay; C Bachelot-Loza; T Kaabache; W Q Liu; B Brohard-Bohn; B Le Bonniec; M Aiach; S Gandrille
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

3.  Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.

Authors:  C Aparicio; B Dahlbäck
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 4.  Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.

Authors:  Hara T Georgatzakou; Sotirios P Fortis; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2022-06-08

5.  The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles.

Authors:  Kaisa E Happonen; Sinh Tran; Matthias Mörgelin; Raja Prince; Sara Calzavarini; Anne Angelillo-Scherrer; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2016-03-22       Impact factor: 5.157

6.  Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy.

Authors:  Aleksandra Lenart-Migdalska; Leszek Drabik; Magdalena Kaźnica-Wiatr; Lidia Tomkiewicz-Pająk; Piotr Podolec; Maria Olszowska
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 7.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

Review 8.  Platelet Extracellular Vesicles: Beyond the Blood.

Authors:  Florian Puhm; Eric Boilard; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 8.311

9.  Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia.

Authors:  Andrea Piccin; Ciaran Murphy; Elva Eakins; Jan Kunde; Daisy Corvetta; Angela Di Pierro; Giovanni Negri; Mazzoleni Guido; Laura Sainati; Corrina Mc Mahon; Owen Patrick Smith; William Murphy
Journal:  J Extracell Vesicles       Date:  2015-11-23

10.  Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.

Authors:  Gaetano Zizzo; Justus Guerrieri; Lindsay M Dittman; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.